[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2016 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- 1.88%
YoY- -19.51%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 480,710 483,976 312,940 318,542 317,210 317,880 270,680 46.70%
PBT 49,528 44,704 31,479 33,573 35,328 39,764 49,755 -0.30%
Tax -11,118 -10,232 -4,653 -9,580 -11,790 -8,452 0 -
NP 38,410 34,472 26,826 23,993 23,538 31,312 49,755 -15.85%
-
NP to SH 38,434 34,472 27,115 25,156 24,692 31,372 38,775 -0.58%
-
Tax Rate 22.45% 22.89% 14.78% 28.53% 33.37% 21.26% 0.00% -
Total Cost 442,300 449,504 286,114 294,549 293,672 286,568 220,925 58.91%
-
Net Worth 463,071 463,071 454,703 451,913 446,334 457,492 270,177 43.26%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 13,947 - 18,132 - 13,947 - 15,843 -8.15%
Div Payout % 36.29% - 66.87% - 56.49% - 40.86% -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 463,071 463,071 454,703 451,913 446,334 457,492 270,177 43.26%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 7.99% 7.12% 8.57% 7.53% 7.42% 9.85% 18.38% -
ROE 8.30% 7.44% 5.96% 5.57% 5.53% 6.86% 14.35% -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 172.32 173.49 112.18 114.19 113.71 113.95 162.30 4.07%
EPS 13.76 13.72 9.62 8.60 8.44 11.24 19.17 -19.84%
DPS 5.00 0.00 6.50 0.00 5.00 0.00 9.50 -34.83%
NAPS 1.66 1.66 1.63 1.62 1.60 1.64 1.62 1.64%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 49.97 50.31 32.53 33.11 32.98 33.05 28.14 46.69%
EPS 4.00 3.58 2.82 2.62 2.57 3.26 4.03 -0.49%
DPS 1.45 0.00 1.88 0.00 1.45 0.00 1.65 -8.26%
NAPS 0.4814 0.4814 0.4727 0.4698 0.464 0.4756 0.2809 43.25%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 2.25 2.31 1.98 2.06 2.04 2.55 2.62 -
P/RPS 1.31 1.33 1.76 1.80 1.79 2.24 1.61 -12.85%
P/EPS 16.33 18.69 20.37 22.84 23.05 22.67 11.27 28.07%
EY 6.12 5.35 4.91 4.38 4.34 4.41 8.87 -21.93%
DY 2.22 0.00 3.28 0.00 2.45 0.00 3.63 -27.97%
P/NAPS 1.36 1.39 1.21 1.27 1.28 1.55 1.62 -11.01%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 25/08/17 22/05/17 24/02/17 21/11/16 22/08/16 18/05/16 23/02/16 -
Price 2.03 2.32 2.23 2.10 2.14 2.40 2.61 -
P/RPS 1.18 1.34 1.99 1.84 1.88 2.11 1.61 -18.72%
P/EPS 14.73 18.77 22.94 23.29 24.18 21.34 11.23 19.84%
EY 6.79 5.33 4.36 4.29 4.14 4.69 8.91 -16.58%
DY 2.46 0.00 2.91 0.00 2.34 0.00 3.64 -23.00%
P/NAPS 1.22 1.40 1.37 1.30 1.34 1.46 1.61 -16.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment